Laureates recognized for contributions to climate change, biomedicine, and quantum cryptography.
Device developed within the Department of Civil and Environmental Engineering has the potential to replace damaged organs with lab-grown ones.
SMART's new Critical Analytics for Manufacturing Personalized-Medicine (CAMP) group aims to overcome challenges in life-changing cell therapies.
Industry leaders, patient advocates, and policymakers collaborate to lower barriers to potentially curative treatments.
In Compton Lecture, NIH director details the importance of reaching out to others.
Collins to present “Exceptional Opportunities in Biomedical Research.”
Nanoscale, biodegradable drug-delivery method could provide a year or more of steady doses.
Historic pledge from Eli and Edythe Broad to propel institute into a new decade of biomedical discovery to benefit patients.
With the grant, MIT’s Biomanufacturing Research Program aims to develop new technologies that can rapidly manufacture biologic drugs on the battlefield.
Peter Reddien and Aviv Regev are among 27 top biomedical scientists selected nationwide.